In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection

被引:76
作者
Glorieux, GL
Dhondt, AW
Jacobs, P
Van Langeraert, J
Lameire, NH
De Deyn, PP
Vanholder, RC
机构
[1] Univ Hosp, Dept Internal Med, Div Renal, Ghent, Belgium
[2] Univ Antwerp, Dept Neurol, Middelheim Hosp, B-2020 Antwerp, Belgium
[3] Univ Antwerp, Dept Biomed Sci, Lab Neurochem & Behav, Born Bunge Fdn, B-2020 Antwerp, Belgium
关键词
uremia; atherogenesis; guanidines; inflammation; infection; leukocytes;
D O I
10.1111/j.1523-1755.2004.00631.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The blunted immune response upon stimulation in chronic renal failure (CRF) is often coupled to a baseline inflammatory status which has been related to atherogenesis. Uremic biologic fluids and several specific uremic retention solutes alter cell-mediated immune responses, as well as the interaction of calcitriol with the immune system. Methods. The present study evaluated the influence of different guanidino compounds on DNA synthesis, chemiluminescence production, and CD14 expression of undifferentiated and calcitriol-differentiated HL-60 cells. In a second setup, these guanidino compounds were evaluated for their specific effect on normal human leukocyte oxidative burst activity and tumor necrosis factor-alpha (TNF-alpha) expression. Results. First, several guanidino compounds elicited proinflammatory effects on leukocytes. Methylguanidine and guanidine stimulated the proliferation of undifferentiated HL-60 cells and the antiproliferative effect of calcitriol (P<0.05) was neutralized in the presence of methylguanidine (P<0.05) and guanidinosuccinic acid (P<0.05). The phorbol-myristate-acetate (PMA)-stimulated chemiluminescence production of the calcitriol differentiated HL-60 cells was enhanced in the presence of guanidine (P<0.05). Methylguanidine and guanidinoacetic acid enhanced the lipopolysaccharide (LPS)-stimulated intracellular production of TNF-alpha by normal human monocytes (P<0.05). Second, several guanidino compounds inhibited the function of leukocytes if they were activated. The PMA-stimulated chemiluminescence production of the calcitriol differentiated HL-60 cells was inhibited by the presence of methylguanidine (P<0.05), guanidinoacetic acid (P<0.05) and guanidinosuccinic acid (P<0.05). After incubation of whole blood in the presence of methylguanidine, the Esherichia coli stimulated oxidative burst activity of the granulocyte population was significantly inhibited (P<0.05). In addition, guanidinosuccinic acid had an inhibitory effect on the LPS-stimulated intracellular production of TNF-alpha by human monocytes (P<0.01). Conclusion. Guanidino compounds exert proinflammatory as well as anti-inflammatory effects on monocyte/macrophage function. This could contribute to the altered prevalence of cardiovascular disease and propensity to infection in patients with CRF.
引用
收藏
页码:2184 / 2192
页数:9
相关论文
共 41 条
[1]   In vitro and in vivo TNFα synthesis modulation by methylguanidine, an uremic catabolyte [J].
Autore, G ;
Marzocco, S ;
Sorrentino, R ;
Mirone, VG ;
Baydoun, A ;
Pinto, A .
LIFE SCIENCES, 1999, 65 (11) :PL121-PL127
[2]   THE INDUCIBLE TRANSCRIPTION ACTIVATOR NF-KAPPA-B - REGULATION BY DISTINCT PROTEIN SUBUNITS [J].
BAEUERLE, PA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (01) :63-80
[3]   The immune effects of neuropeptides [J].
Berczi, I ;
Chalmers, IM ;
Nagy, E ;
Warrington, RJ .
BAILLIERES CLINICAL RHEUMATOLOGY, 1996, 10 (02) :227-257
[4]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[5]  
Cohen G, 1997, MINER ELECTROL METAB, V23, P210
[6]  
Cohen G, 2001, J AM SOC NEPHROL, V12, P1264, DOI 10.1681/ASN.V1261264
[7]   Endogenous guanidino compounds as uremic neurotoxins [J].
De Deyn, PP ;
D'Hooge, R ;
Van Bogaert, PP ;
Marescau, B .
KIDNEY INTERNATIONAL, 2001, 59 :S77-S83
[8]   GUANIDINO COMPOUNDS IN UREMIC DIALYZED PATIENTS [J].
DEDEYN, P ;
MARESCAU, B ;
LORNOY, W ;
BECAUS, I ;
LOWENTHAL, A .
CLINICA CHIMICA ACTA, 1986, 157 (02) :143-150
[9]   GUANIDINO COMPOUND LEVELS IN BRAIN-REGIONS OF NON-DIALYZED UREMIC PATIENTS [J].
DEDEYN, PP ;
MARESCAU, B ;
DHOOGE, R ;
POSSEMIERS, I ;
NAGLER, J ;
MAHLER, C .
NEUROCHEMISTRY INTERNATIONAL, 1995, 27 (03) :227-237
[10]   GUANIDINO COMPOUNDS IN SERUM AND CEREBROSPINAL-FLUID OF NON-DIALYZED PATIENTS WITH RENAL-INSUFFICIENCY [J].
DEDEYN, PP ;
MARESCAU, B ;
CUYKENS, JJ ;
VANGORP, L ;
LOWENTHAL, A ;
DEPOTTER, WP .
CLINICA CHIMICA ACTA, 1987, 167 (01) :81-88